Informations générales (source: ClinicalTrials.gov)

NCT04405869 Statut inconnu
Incidence of Thromboembolic Events and Prognosis of COVID-19 Patients Hospitalized in Intensive Care Units in France (COVICLOT)
Observational
  • Embolie pulmonaire
  • Thromboembolie
University Hospital, Strasbourg, France (Voir sur ClinicalTrials)
avril 2020
avril 2021
29 juin 2024
The main objective of this study is to describe the incidence of thromboembolic events in a population of patients hospitalized in intensive care units in France for severe COVID-19. The secondary objective of this study is to describe the evolution of hemostasis parameters during the first two weeks of intensive care hospitalization and to evaluate the influence of different anticoagulation regimens on these parameters and on the incidence of thromboembolic events
 Voir le détail

Etablissements

Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
Service d'Anesthésie-Réanimation - Nouvel Hôpital Civil - 67091 - Strasbourg - France Charles TACQUARD, MD En recrutement Contact (sur clinicalTrials)

Critères

Tous
Inclusion Criteria:

- Confirmed infection with the Sars-CoV-2 virus (RT-PCR)

- Hospitalization in Intensive Care Unit

- Age over 18 years Old


- Refusal of the patient to participate in data collection